These clinical studies are to evaluate the efficacy and safety of Pluseed in improving the quality of semen. These studies are conducted over 16 weeks at various institutions.
To determine the efficacy and safety of Pluseed in selected cases of male factor infertility.
Infertile patients with the following baseline sperm selection criteria: total motility: 30-70%
Patients underwent Pluseed therapy; 16 weeks of therapy.
Variation in sperm parameters included progressive motility, sperm cell density, morphology and ejaculatory volume used in the patient selection criteria.